Frequently asked questions about the ISAPP postbiotic definition

被引:13
|
作者
Vinderola, Gabriel [1 ]
Sanders, Mary Ellen [2 ]
Cunningham, Marla [3 ]
Hill, Colin [4 ]
机构
[1] Natl Univ Litoral, Fac Chem Engn, Inst Lactol Ind CONICET UNL, Santa Fe, Argentina
[2] Int Sci Assoc Probiot & Prebiot, Centennial, CO USA
[3] Int Sci Assoc Probiot & Prebiot, Brisbane, Qld, Australia
[4] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland
关键词
postbiotics; International Scientific Association for Probiotics and Prebiotics; ISAPP; biotic; inanimate microorganism; INTERNATIONAL SCIENTIFIC ASSOCIATION; IRRITABLE-BOWEL-SYNDROME; CONSENSUS STATEMENT; DOUBLE-BLIND; PROBIOTICS; PREBIOTICS; BACTERIA; SCOPE;
D O I
10.3389/fmicb.2023.1324565
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The term postbiotic was defined by the International Scientific Association of Probiotics and Prebiotics (ISAPP) as "a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host." Although the ISAPP definition is widely cited, some concerns were aired after publication, and alternative definitions of postbiotic, as well as different terms for inactivated microbes, have been previously suggested. This paper addresses questions about the ISAPP definition that have been raised in different forums, including scientific meetings, social media commentary and personal communications. We focus on the rationale, scope, wording, composition and commercial implementation, as well as what is expected of postbiotics regarding safety, efficacy, quantification and mechanisms of action. We hope that exploring these questions will further clarify the definition and its scope and support a common understanding of the concept of postbiotics.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Frequently Asked Questions About Hydrogen Carrier Gas
    Hinshaw, John V.
    LC GC EUROPE, 2009, 22 (01) : 32 - +
  • [22] Frequently Asked Questions About Education in Addiction Psychiatry
    John T. Pichot
    John T. Harris
    Alison R. Jones
    Academic Psychiatry, 1998, 22 : 253 - 257
  • [23] Frequently asked questions about analytical method validation
    Krull, I
    Swartz, M
    LC GC-MAGAZINE OF SEPARATION SCIENCE, 1998, 16 (05): : 464 - +
  • [24] Frequently asked questions about naloxone: Part 2
    Cid, Ashley
    Patten, Alec
    Grindrod, Kelly
    Beazely, Michael A.
    CANADIAN PHARMACISTS JOURNAL, 2021, 154 (06) : 385 - 387
  • [25] Frequently asked questions about the paperless meetings process
    不详
    AEROSPACE AMERICA, 2005, 43 (09) : B6 - B6
  • [26] Frequently asked questions about education in addiction psychiatry
    Pichot, JT
    Harris, JT
    Jones, AR
    ACADEMIC PSYCHIATRY, 1998, 22 (04) : 253 - 257
  • [27] Frequently asked questions about chlorophyll fluorescence, the sequel
    Hazem M. Kalaji
    Gert Schansker
    Marian Brestic
    Filippo Bussotti
    Angeles Calatayud
    Lorenzo Ferroni
    Vasilij Goltsev
    Lucia Guidi
    Anjana Jajoo
    Pengmin Li
    Pasquale Losciale
    Vinod K. Mishra
    Amarendra N. Misra
    Sergio G. Nebauer
    Simonetta Pancaldi
    Consuelo Penella
    Martina Pollastrini
    Kancherla Suresh
    Eduardo Tambussi
    Marcos Yanniccari
    Marek Zivcak
    Magdalena D. Cetner
    Izabela A. Samborska
    Alexandrina Stirbet
    Katarina Olsovska
    Kristyna Kunderlikova
    Henry Shelonzek
    Szymon Rusinowski
    Wojciech Bąba
    Photosynthesis Research, 2017, 132 : 13 - 66
  • [28] Five Frequently Asked Questions about Thermal Desorption
    Martin, Helen
    LCGC NORTH AMERICA, 2022, 40 (08) : 398 - 398
  • [29] Frequently asked questions about naloxone: Part 3
    Cid, Ashley
    Patten, Alec
    Grindrod, Kelly
    Beazely, Michael A.
    CANADIAN PHARMACISTS JOURNAL, 2022, 155 (01) : 9 - 11
  • [30] Five Frequently Asked Questions about Thermal Desorption
    Miles, Laura
    LC GC NORTH AMERICA, 2021, 39 (08) : 369 - 369